CUSIP: 23954D109
Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
103,269,345
-
Total 13F shares
-
78,803,713
-
Share change
-
+17,603,439
-
Total reported value
-
$941,011,552
-
Put/Call ratio
-
77%
-
Price per share
-
$11.94
-
Number of holders
-
136
-
Value change
-
+$208,122,003
-
Number of buys
-
98
-
Number of sells
-
46
Security key
23954D109
Report period
Q2 2023
Institutions
136
Top holders
10
Reporting periods
Holder history for CUSIP 23954D109
Recent filing periods:
Top shareholders of DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q2 2023
As of 30 Jun 2023,
Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
78,803,713 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., Atlas Venture Life Science Advisors, LLC, FMR LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, BlackRock Inc., BRAIDWELL LP, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, and Canaan Partners XI LLC.
This page lists
137
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
Compare Q2 2023 vs Q1 2023 Across Filers
| Investor |
Q1 2023 Shares |
Q2 2023 Shares |
Share Diff |
Share Chg % |
Q1 2023 Value $ |
Q2 2023 Value $ |
Value Diff $ |
Value Chg % |
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.